Lollo CP - Search Results

1

Therapy of peritoneal carcinomatosis of human colon cancer xenografts with yttrium 90-labeled anti-carcinoembryonic antigen antibody ZCE025.

Hyams DM, Esteban JM, Lollo CP, Beatty BG, Beatty JD. Hyams DM, et al. Among authors: lollo cp. Arch Surg. 1987 Nov;122(11):1333-7. doi: 10.1001/archsurg.1987.01400230121021. Arch Surg. 1987. PMID: 3675197

2

Liver toxicity induced by combined external-beam irradiation and radioimmunoglobulin therapy.

Wang S, Quadri SM, Tang XZ, Stephens LC, Lollo CP, Bartholomew RM, Vriesendorp HM. Wang S, et al. Among authors: lollo cp. Radiat Res. 1995 Mar;141(3):294-302. Radiat Res. 1995. PMID: 7871156

3

90Yttrium antiferritin--a new therapeutic radiolabeled antibody.

Order SE, Klein JL, Leichner PK, Frincke J, Lollo C, Carlo DJ. Order SE, et al. Int J Radiat Oncol Biol Phys. 1986 Feb;12(2):277-81. doi: 10.1016/0360-3016(86)90110-0. Int J Radiat Oncol Biol Phys. 1986. PMID: 3005201

4

Non-covalent antibody-mediated drug delivery.

Lollo C, Halpern S, Bartholomew R, David G, Hagan P. Lollo C, et al. Nucl Med Commun. 1994 Jun;15(6):483-91. doi: 10.1097/00006231-199406000-00014. Nucl Med Commun. 1994. PMID: 8078646

5

Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma.

Foss FM, Raubitscheck A, Mulshine JL, Fleisher TA, Reynolds JC, Paik CH, Neumann RD, Boland C, Perentesis P, Brown MR, Frincke JM, Lollo CP, Larson SM, Carrasquillo JA. Foss FM, et al. Among authors: lollo cp. Clin Cancer Res. 1998 Nov;4(11):2691-700. Clin Cancer Res. 1998. PMID: 9829731 Clinical Trial.

6

An open-label, randomized, single-dose, two-period, two-treatment crossover bioavailability study comparing 5 mg/0.5 mL of intramuscular naloxone hydrochloride to 2 mg/0.4 mL intramuscular naloxone hydrochloride autoinjector in healthy subjects.

Moss RB, Carleton F, Lollo CP, Carlo DJ. Moss RB, et al. Among authors: lollo cp. J Opioid Manag. 2020 May/Jun;16(3):209-214. doi: 10.5055/jom.2020.0569. J Opioid Manag. 2020. PMID: 32421841 Clinical Trial.

7

Non-viral gene delivery: vehicle and delivery characterization.

Lollo CP, Kwoh DY, Mockler TC, Ley PM, Guido MS, Coffin CC, Aleman R, Bartholomew RM, Carlo DJ. Lollo CP, et al. Blood Coagul Fibrinolysis. 1997 Dec;8 Suppl 2:S31-8. Blood Coagul Fibrinolysis. 1997. PMID: 9607111

8

Stabilization of poly-L-lysine/DNA polyplexes for in vivo gene delivery to the liver.

Kwoh DY, Coffin CC, Lollo CP, Jovenal J, Banaszczyk MG, Mullen P, Phillips A, Amini A, Fabrycki J, Bartholomew RM, Brostoff SW, Carlo DJ. Kwoh DY, et al. Among authors: lollo cp. Biochim Biophys Acta. 1999 Feb 16;1444(2):171-90. doi: 10.1016/s0167-4781(98)00274-7. Biochim Biophys Acta. 1999. PMID: 10023051

9

Poly-L-lysine-based gene delivery systems. Synthesis, purification, and application.

Lollo CP, Banaszczyk MG, Mullen PM, Coffin CC, Wu D, Carlo AT, Bassett DL, Gouveia EK, Carlo DJ. Lollo CP, et al. Methods Mol Med. 2002;69:1-13. doi: 10.1385/1-59259-141-8:001. Methods Mol Med. 2002. PMID: 11987770 No abstract available.

10

Strength of conjugate binding to plasmid DNA affects degradation rate and expression level in vivo.

Mullen PM, Lollo CP, Phan QC, Amini A, Banaszczyk MG, Fabrycki JM, Wu D, Carlo AT, Pezzoli P, Coffin CC, Carlo DJ. Mullen PM, et al. Among authors: lollo cp. Biochim Biophys Acta. 2000 Sep 1;1523(1):103-10. doi: 10.1016/s0304-4165(00)00104-5. Biochim Biophys Acta. 2000. PMID: 11099863

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters